Interviews on biotechnology

Interview 3 Sep 2018

Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs

According to John LaMattina in Forbes last year, more and more senior scientific executives are moving from pharma to small biotechs or startup initiatives. While the jury is out on whether this observation reflects a real trend or not, we at Labiotech are keen to learn about what drives people to make such a move! […]

September 3, 2018 - 11 minutesmins - By External Contributor

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us their story, from the drug’s early days to their current role as executives of the biotech unicorn Aduro. Since 2014, the cancer drug Keytruda, also known as pembrolizumab, continues to be widely sought after due […]

July 24, 2018 - 6 minutesmins - By Editorial Team

antimicrobial resistance molecular diagnostics 1

Interview 3 Jul 2018

Fighting Antimicrobial Resistance with Fast Molecular Diagnostics

Antimicrobial resistance is predicted to kill more people than cancer by 2050. Is it possible to prevent it? At our Refresh Meetup in Berlin, I talked with Achim Plum, CBO of the diagnostics company Curetis, about what are our best bets to turn the tables in the fight against the threat of antimicrobial resistance. The […]

July 3, 2018 - 8 minutesmins - By Clara Rodríguez Fernández

Interview 28 Jun 2018

The Race to Get CRISPR to the Clinic: Hope Versus Hype

In 2016, German pharma giant Bayer took a bold step and decided to partner with CRISPR Therapeutics to form a company that could join the race to be first into the clinic with a CRISPR therapy. Peter Nell worked at Bayer for many years and was one of the founding team of Casebia Therapeutics. Now […]

June 28, 2018 - 7 minutesmins - By Helen Albert

Interview 22 Jun 2018

Swedish Biotech’s Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses

Elypta is developing liquid biopsies that analyze cancer metabolism to make cancer diagnoses more accurate. Philip talked to Francesco Gatto, Elypta’s Chief Scientific Officer and a co-founder, on their technology, moving from academia to industry, and the challenges of starting a biotech company. Even though biotechs and pharma companies across the globe have been pouring […]

June 22, 2018 - 5 minutesmins - By Alexander Burik

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

Some careers take on an international scope and span the breadth of big players in the pharmaceutical industry and small biotech startups. David Ebsworth, Chairman at Verona Pharma, can count his professional journey among these and gave us the inside scoop on the successes and challenges he faced, his perspective on European biotech, and advice to […]

June 20, 2018 - 9 minutesmins - By Alexander Burik

Interview 13 Jun 2018

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

CAR-T cell therapy has been able to effectively treat cancer in some patients for whom all other treatment options were exhausted. However, the technology still has a long road ahead before becoming a widespread treatment option. Philip spoke to Christian Homsy, CEO of Celyad, at our Refresh Meetup in Brussels about the challenges CAR-T cell […]

June 13, 2018 - 5 minutesmins - By Alexander Burik

Interview 4 Jun 2018

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

The synbio company AMSilk is drawing inspiration from nature to produce sustainable materials for applications ranging from clothing to medicine. I spoke to CEO Jens Klein to find out more about the innovative biodegradable material that has caught Adidas’ eye. In 2016, Adidas showed the world the first prototype of a new running shoe that, […]

June 4, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

Interview 30 May 2018

How to Close a €3.9B Acquisition Deal for Your Biotech Company

Ablynx, one of the big giants in the European biotech arena, closed the final stages of its €3.9B acquisition deal with Sanofi earlier this month, after details were announced in January. Edwin Moses, CEO of Ablynx, shared the company’s success story with attendees at our recent Refresh Meetup in Brussels. The technology behind Ablynx’s success […]

May 30, 2018 - 7 minutesmins - By Helen Albert

pili tolouse white biotechnology twb bioreactor

Interview 24 May 2018

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

The commercial dyeing industry is not known for being eco-friendly, which is something that PILI – a synbio startup based in France – is hoping to address with their color producing microbes. Philip chatted with its CEO, Jeremie Blache, to find out more about the company, its recent successful fundraising round and how its technology […]

May 24, 2018 - 5 minutesmins - By Helen Albert

Interview 21 May 2018

Engineering Red Blood Cells to Fight the Most Severe Cancers

Our very own red blood cells could soon become a treatment for some of the most severe forms of cancer; After a long journey of ups and downs, Erytech is now near the finish line to launch the first red blood cell therapy. How amazing would it be if we could use our own cells […]

May 21, 2018 - 6 minutesmins - By Alexander Burik

cambridge cancer genomics liquid biopsy ai

Interview 2 May 2018

Combining Liquid Biopsy and Artificial Intelligence to Outrun Cancer

Making liquid biopsy and artificial intelligence technologies work together could help doctors make faster decisions to treat cancer on time. Philip talked to the CEO of Cambridge Cancer Genomics to find out what this approach can mean for the treatment of cancer. Although much progress has been made in recent years, cancer remains one of […]

May 2, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Interview

Moving from Big Pharma to Biotech – Insights from Two Biotech CEOs

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Fighting Antimicrobial Resistance with Fast Molecular Diagnostics

The Race to Get CRISPR to the Clinic: Hope Versus Hype

Swedish Biotech’s Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

Meet the German Biotech Behind Adidas’ Biodegradable Shoes

How to Close a €3.9B Acquisition Deal for Your Biotech Company

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

Engineering Red Blood Cells to Fight the Most Severe Cancers

Combining Liquid Biopsy and Artificial Intelligence to Outrun Cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!